Splice it up: Atypical transcripts to boost leukemia immunotherapy.
Immunity
; 54(4): 608-610, 2021 04 13.
Article
em En
| MEDLINE
| ID: mdl-33852826
ABSTRACT
Neoantigens are prime targets for cancer immunotherapy, but their identification in low mutational burden malignancies remains challenging. In this issue of Immunity, Ehx et al. show that atypical transcripts, and particularly retained introns, expand the spectrum of leukemia immunotherapy targets.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Leucemia
/
Neoplasias
Limite:
Humans
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article